National Health Investors Price Target Raised to $78.00/Share From $65.00 by Truist Securities
National Health Investors Analyst Ratings
BofA Securities Maintains Duke Energy(DUK.US) With Hold Rating
Duke Energy Analyst Ratings
RBC Capital Maintains Duke Energy(DUK.US) With Buy Rating, Raises Target Price to $135
Deutsche Bank Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $90
DA Davidson Adjusts Price Target on Duke Energy to $125 From $110, Maintains Buy Rating
Stifel Maintains Altria(MO.US) With Buy Rating
Kinder Morgan Analyst Ratings
Deutsche Bank Raises Price Target on National Health Investors to $90 From $69, Keeps Buy Rating
Stifel Maintains Kinder Morgan(KMI.US) With Hold Rating, Raises Target Price to $23
Stifel Adjusts Price Target on Kinder Morgan to $23 From $22, Maintains Hold Rating
Omega Healthcare Invts Analyst Ratings
Scotiabank Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $39
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $81
Wells Fargo Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Raises Target Price to $40
Citi Initiates Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Announces Target Price $42
Stifel Maintains Altria(MO.US) With Buy Rating, Maintains Target Price $54
Argus Research Initiates Duke Energy(DUK.US) With Buy Rating
Argus Research Adjusts Duke Energy Price Target to $125 From $115, Buy Rating Maintained